Dafna Capital Management LLC Bicycle Therapeutics PLC Transaction History
Dafna Capital Management LLC
- $331 Million
- Q1 2025
A detailed history of Dafna Capital Management LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Dafna Capital Management LLC holds 80,799 shares of BCYC stock, worth $650,431. This represents 0.21% of its overall portfolio holdings.
Number of Shares
80,799
Previous 120,799
33.11%
Holding current value
$650,431
Previous $1.69 Million
59.49%
% of portfolio
0.21%
Previous 0.46%
Shares
5 transactions
Others Institutions Holding BCYC
# of Institutions
101Shares Held
42.8MCall Options Held
15.6KPut Options Held
27.7K-
Baker Bros. Advisors LP New York, NY10.9MShares$87.6 Million1.1% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.69MShares$29.7 Million0.08% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$27.8 Million7.08% of portfolio
-
Armistice Capital, LLC New York, NY2.67MShares$21.5 Million0.35% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.66MShares$21.4 Million0.12% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $239M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...